Video Feature


FDA Risk vs. Benefit: The Drug Safety Debate After 50 Years

Length: [11:10]

Why thalidomide shows that drug safety is not a black-and-white issue. A former FDA official explains why thalidomide was brought back. And patient and consumer groups debate risk tolerance and the need for incentives to create new treatments.

More Videos